Topical Silver Nanoparticles for Microbial Activity
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT03752424|
Recruitment Status : Recruiting
First Posted : November 26, 2018
Last Update Posted : November 26, 2018
|Condition or disease||Intervention/treatment||Phase|
|Foot Infection Fungal Infection, Bacterial||Drug: Silver nanoparticles Drug: Topical approved anti-microbial gel||Phase 1|
- Preparation of vanishing cream Vanishing cream is an emulsion base which is oil in water, the oil phase gives the cream shine and pearl look because of stearic acid in the oil. To form an emulsion, the alkali will react with stearic acid to form stearate soap. Then mix sodium hydroxide (NaOH) with potassium hydroxide (KOH) to give cream hard and soft properties.
- Preparation of cream containing silver nanoparticles Silver nanoparticles will be produced by using the reduction reaction method. The reaction involves heating silver nitrate at a high temperature with adding a reducing agent, the particles will produce as silver nanoparticles in liquid form.
Characterization of the Vanishing cream containing drug:
3.1. Drug content: The amount of drug in cream will be determined by taking 100 mg of the cream formulation and dissolve it in 10 mL of methanol after that it will be filtrated. In addition, it will be analyzed the content of drug spectrophotometrically using (UV-VIS) at specific λmax.
3.2. Irritation to skin: In this test, the cream formulation will be applied to four healthy volunteers which they should not have any sensitivity to the drug. They will inform about the nature of the formulation and obtain a written approval from them about the irritation effect of the formulated cream.
- Anti-microbial studies:
The antifungal action for formula will be studied using different 6 groups volunteers The inhibition microbial activity for all formulae were compared with known standard antimicrobial drugs.
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||30 participants|
|Intervention Model:||Parallel Assignment|
|Official Title:||Topical Silver Nanoparticles for Microbial Activity|
|Estimated Study Start Date :||January 13, 2019|
|Estimated Primary Completion Date :||January 12, 2020|
|Estimated Study Completion Date :||January 11, 2021|
Active Comparator: Silver nanoparticles group
A group of volunteers infected with Tinea pedis, Capitis and Versicolor received Topical silver nanoparticles in different dosage forms.
Drug: Silver nanoparticles
The active group will receive silver nanoparticles in different dosage forms as an anti-microbial drug.
Other Name: Topical jel
Placebo Comparator: Topical approved anti-microbial gel
A group of volunteers infected with Tinea pedis, Capitis and Versicolor received placebo cream.
Drug: Topical approved anti-microbial gel
The placebo group will receive topical FDA approved anti-microbial jel in different dosage forms as control drug.
Other Name: Topical anti-microbial gel
- The antimicrobial activity of silver nanoparticles in the two groups of control and an infected patient will be determined. Each group will be of 6 volunteers, each one will be controlled for the CTCAE. [ Time Frame: Six months ]The formulated silver nanoparticles are expected to be with anti-microbial after applying activity with infected patients even systemically or topically. The nanoparticles will be examined on two groups of patients (control group, and patient with fungal or microbial infections). Moreover, the obtained silver nanoparticles are expected to highly internalized and disease targeted. The results will be compared with control groups to prove the anti-microbial Activity. The progress of treating the patient will be noticed by completely disappear of fungal infection.
- Stable topical anti-microbial silver nanoparticles [ Time Frame: three months ]Stability test will be studied for dosage forms. The test will carried out by standing the products on shelf life for three months. The stability test will be recorded using high performance liquid chromatography each thee days.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03752424
|Contact: Ahmed AH Abdellatif, Ph.D.||+966507726856 ext firstname.lastname@example.org|
|Contact: Ahmed AH Abdellatif|
|Buraidah, Al Qassim, Saudi Arabia, 51171|
|Contact: Ahmed AH Abdellatif, Ph.D. +966507726856 email@example.com|